Dr. Ahmed Maged Alabbady, MD

Dr. Alabbady practices at Bon Secours Charity Health System Medical Group in Warwick, New York.

Dr. Alabbady's NPI, 1790030153, was assigned on July 20, 2012. Dr. Alabbady holds New York license 317265.

Dr. Alabbady's primary practice is Bon Secours Charity Health System Medical Group, at 20 Grand St, Warwick, NY 10990 in Orange County. The practice phone is (845) 987-3906.

Dr. Alabbady's primary practice is Bon Secours Charity Health System Medical Group in Warwick, New York. Dr. Alabbady is also affiliated with St. Anthony Community Hospital. The medical group on file is Westchester Medical Center Advanced Physician Services. Dmand AI also links Dr. Alabbady to 4 more hospitals, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Alabbady practices, 6 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Alabbady's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Alabbady is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Alabbady's licenses on file in 4 states: New York, Virginia, New Jersey and Pennsylvania.

Dmand AI lists angioplasty and cardiac catheterization among the conditions Dr. Alabbady treats.

CMS data shows 2,119 Medicare services from Dr. Alabbady across 30 procedure codes in 2024, for 759 Medicare patients. Medicare paid $200,448 for them.

CMS counts 759 Medicare patients who saw Dr. Alabbady in 2024. The largest group is 75 to 84, with 312 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 22% are also on Medicaid. Their average risk score is 1.85, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Alabbady's median patient age at 70, with 47% women.

In 2024, Dr. Alabbady wrote 1,105 Medicare Part D claims for 284 patients. 85% of them were for generic drugs. CMS names the drug for 934 of them, across 21 drugs with 11 or more claims each, at $166,279 in total drug cost. In 2023, CMS named 380 claims across 15 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Dr. Alabbady for performance year 2024, reported through an alternative payment model (APM). Dr. Alabbady accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Alabbady as offering telehealth. CMS counts 25 procedures of coronary angioplasty and stenting by Dr. Alabbady, more than 58% of the clinicians it reports for that procedure.

Pacemaker insertion or repair: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 2 papers to Dr. Alabbady in 2019. Dr. Alabbady's most frequent co-author is Sudhakar Sattur, MD.

CMS Open Payments shows 192 general payments to Dr. Alabbady from 26 drug and device companies from 2016 to 2025. Grants make up the largest share, 71% of the total. Medtronic, Inc. paid the most, $22,838.

Dr. Alabbady is in network with 17 carriers, including Aetna, MVP Health Care and United Healthcare. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.